Patents-Review.com
ClassID:

110000 ⎘

C12N2710/24043 - CPC Classification

Classification description:

dsDNA viruses; Details; Poxviridae; Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector

Recent Application in this class:
#1
20250032766
2025-01-30

NON-INVASIVE AGENT APPLICATOR

 #2
20240316130
2024-09-26

COMPOSITION AND METHODS INCLUDING RECOMBINANT VIRUSES MODULATING ARGININE BIOSYNTHESIS

 #3
20240261389
2024-08-08

AMINO ACIDS, NUCLEOTIDES AND VECTORS EXPRESSING THE SAME AND USES THEREOF IN PREVENTING SARBECOVIRUS INFECTION

 #4
20240245765
2024-07-25

Use of Ectromelia Virus for Cancer Immunotherapy and Vaccines

 #5
20240238409
2024-07-18

SARS-COV-2 MULTI-EPITOPE VACCINES

 #6
20240156869
2024-05-16

METHODS OF ENHANCING DIVERSITY OF HLA HAPLOTYPE EXPRESSION IN TUMORS TO BROADEN TUMOR CELL SUSCEPTIBILITY TO TCR-T THERAPY

 #7
20240092852
2024-03-21

MULTI-ARMED MYXOMA VIRUS

 #8
20230151387
2023-05-18

COVID-19 VACCINE BASED ON THE MYXOMA VIRUS PLATFORM

 #9
20230029453
2023-02-02

Prostate neoantigens and their uses

 #10
20220105171
2022-04-07

Materials and methods for respiratory disease control in canines

 #11
20220088172
2022-03-24

Poxvirus vectors encoding HIV antigens, and methods of use thereof

 #12
20220088096
2022-03-24

ONCOLYTIC MYXOMA VIRUS EXPRESSING FAST P14 TO TREAT HEMATOLOGICAL CANCER

 #13
20220047694
2022-02-17

AFRICAN SWINE FEVER VIRUS VACCINE

 #14
20220002750
2022-01-06

Recombinant viral vector, immune composition containing same, and use thereof

 #15
20210260353
2021-08-26

Non-invasive agent applicator

 #16
20210205429
2021-07-08

Combination Therapy for Treating Cancer with a Poxvirus Expressing a Tumor Antigen and an Antagonist of an Immune Checkpoint Inhibitor

 #17
20210171981
2021-06-10

Viral vectors encoding cancer/testis antigens for use in a method of prevention or treatment of cancer

 #18
20210145961
2021-05-20

Prime/boost immunization regimen against HIV-1 utilizing a multiepitope T cell immunogen comprising Gag, Pol, Vif, and Nef epitopes

 #19
20200397890
2020-12-24

Antiviral vaccines with improved cellular immunogenicity

 #20
20200390878
2020-12-17

RECOMBINANT SWINEPOX VIRUS AND VACCINES

 #21
20200325477
2020-10-15

Compositions and Methods for Inducing an Enhanced Immune Response Using Poxvirus Vectors

 #22
20200206339
2020-07-02

Recombinant viral vector systems expressing exogenous feline paramyxovirus genes and vaccines made therefrom

 #23
20200190538
2020-06-18

Avian oncolytic virus having modified sequences and uses thereof

 #24
20200138938
2020-05-07

Poxvirus vectors encoding HIV antigens, and methods of use thereof

 #25
20190314492
2019-10-17

Antiviral vaccines with improved cellular immunogenicity

 #26
20190314488
2019-10-17

Materials and methods for respiratory disease control in canines

 #27
20190307876
2019-10-10

Multivalent recombinant SPV

 #28
20190263883
2019-08-29

METHOD FOR AUGMENTING VISION IN PERSONS SUFFERING FROM PHOTORECEPTOR CELL DEGENERATION

 #29
20190247491
2019-08-15

Methods for inducing an immune response against human immunodeficiency virus infection in subjects undergoing antiretroviral treatment

 #30
20190224301
2019-07-25

Methods and compositions for inducing protective immunity against a marburg virus infection

 #31
20190201549
2019-07-04

Drug delivery system based on JCV-VLP

 #32
20180296700
2018-10-18

NOVEL DRUG DELIVERY SYSTEM BASED ON JCV-VLP

 #33
20180216134
2018-08-02

Cassette encoding a FPV/brachyury fusion protein

 #34
20180169217
2018-06-21

Materials and methods for respiratory disease control in canines

 #35
20180064803
2018-03-08

Methods for inducing an immune response against human immunodeficiency virus infection in subjects undergoing antiretroviral treatment

 #36
20170340721
2017-11-30

Methods and compositions for enhancing immune responses

 #37
20170335343
2017-11-23

Recombinant swinepox virus and vaccines

 #38
20170333550
2017-11-23

Poxviral vaccines

 #39
20170312490
2017-11-02

Non-Invasive Agent Applicator

 #40
20170239344
2017-08-24

Antiviral vaccines with improved cellular immunogenicity

 #41
20170137843
2017-05-18

Recombinant poxviral vectors expressing both rabies and OX40 proteins, and vaccines made therefrom

 #42
20170087242
2017-03-30

Hendra virus recombinant compositions and uses thereof

 #43
20170052185
2017-02-23

BIOMARKERS FOR PROSTATE CANCER AND METHODS FOR THEIR DETECTION

 #44
20160312225
2016-10-27

Immune regulatory oligonucleotide (IRO) compounds to modulate toll-like receptor based immune response

 #45
20160271239
2016-09-22

Combination Therapy for Treating Cancer with a Poxvirus Expressing a Tumor Antigen and an Antagonist and/or Agonist of an Immune Checkpoint Inhibitor

 #46
20160220658
2016-08-04

PCV2B divergent vaccine composition and methods of use

 #47
20160201060
2016-07-14

Immune regulatory oligonucleotide (IRO) compounds to modulate toll-like receptor based immune response

 #48
20160199483
2016-07-14

Recombinant CDV compositions and uses thereof

 #49
20160193296
2016-07-07

METHODS FOR TREATMENT OF MICROCEPHALY ASSOCIATED AUTISM DISORDERS

 #50
20160108431
2016-04-21

PREVENTION AND TREATMENT OF ATRIAL FIBRILLATION

 #51
20160046676
2016-02-18

Fusion polypeptides and vaccines

 #52
20160030551
2016-02-04

Single high dose of MVA induces a protective immune response in neonates and infants

 #53
20160024156
2016-01-28

Antiviral vaccines with improved cellular immunogenicity

 #54
20160022841
2016-01-28

Method for augmenting vision in persons suffering from photoreceptor cell degeneration

 #55
20150283228
2015-10-08

Recombinant feline leukemia virus vaccine containing optimized feline leukemia virus envelope gene

 #56
20150056235
2015-02-26

Materials and methods for respiratory disease control in canines

 #57
20150030623
2015-01-29

Recombinant feline leukemia virus vaccine containing optimized feline leukemia virus envelope gene

 #58
20140335126
2014-11-13

Immunogens comprising human immunodeficiency virus V1/V2 polypeptides

 #59
20140193396
2014-07-10

Immune regulatory oligonucleotide (IRO) compounds to modulate toll-like receptor based immune response

 #60
20130209511
2013-08-15

Recombinant poxviral vectors expressing both rabies and OX40 proteins, and vaccines made therefrom

 #61
20130156813
2013-06-20

Biomarkers for prostate cancer and methods for their detection

 #62
20130022632
2013-01-24

Recombinant feline leukemia virus vaccine containing optimized feline leukemia virus envelope gene

 #63
20120308593
2012-12-06

Immunological Compositions for HIV

 #64
20120301479
2012-11-29

HENDRA VIRUS RECOMBINANT COMPOSITIONS AND USES THEREOF

 #65
20120183569
2012-07-19

Recombinant feline leukemia virus vaccine containing optimized feline leukemia virus envelope gene

 #66
20120114691
2012-05-10

VACCINE AGAINST AFRICAN HORSE SICKNESS VIRUS

 #67
20120076812
2012-03-29

Antiviral vaccines with improved cellular immunogenicity

 #68
20110319480
2011-12-29

Method of Inducing and/or Enhancing an Immune Response to Tumor Antigens

 #69
20110311586
2011-12-22

Materials and methods for respiratory disease control in canines

 #70
20110236419
2011-09-29

Recombinant CDV compositions and uses thereof

 #71
20110165645
2011-07-07

Methods Using Ion Exchange and Gel Filtration Chromatography for Poxvirus Purification

 #72
20110159034
2011-06-30

METHODS AND REAGENTS FOR VACCINATION WHICH GENERATE A CD8 T CELL IMMUNE RESPONSE

 #73
20110052626
2011-03-03

LEPORIPOXVIRUS-DERIVED VACCINE VECTORS

 #74
20100291037
2010-11-18

IMMUNOGENICITY USING A COMBINATION OF DNA AND VACCINIA VIRUS VECTOR VACCINES

 #75
20100278862
2010-11-04

Nipah virus vaccines

 #76
20100260807
2010-10-14

Methods of Inducing and/or Enhancing an Immune Response To Tumor Antigens

 #77
20100221282
2010-09-02

Recombinant vaccine against West Nile Virus

 #78
20100136056
2010-06-03

NOVEL INSERTION SITES IN POX VECTORS

 #79
20100119551
2010-05-13

Methods and reagents for vaccination which generate a CD8 T cell immune response

 #80
20100119546
2010-05-13

Vaccine against african horse sickness virus

 #81
20100041023
2010-02-18

Inactivated FCV vaccines

 #82
20090324632
2009-12-31

Methods and reagents for vaccination which generate a CD8 T cell immune response

 #83
20090253185
2009-10-08

AVIPOX RECOMBINANTS EXPRESSING FOOT AND MOUTH DISEASE VIRUS GENES

 #84
20090227658
2009-09-10

Methods and compositions for immunization against hiv

 #85
20090191237
2009-07-30

Methods and reagents for vaccination which generate A CD8 T cell immune response

 #86
20090162837
2009-06-25

Inactivated FCV vaccines

 #87
20090142373
2009-06-04

Immunizing Against HIV Infection

 #88
20090041804
2009-02-12

Recombinant vector expressing multiple costimulatory molecules and uses thereof

 #89
20080299141
2008-12-04

Raccoon Poxvirus Expressing Genes of Porcine Virus

 #90
20080241184
2008-10-02

CANINE INFLUENZA VACCINES

 #91
20080188640
2008-08-07

Immunodeficiency recombinant poxvirus

 #92
20080166367
2008-07-10

Custom vectors for treating and preventing pancreatic cancer

 #93
20080124357
2008-05-29

Vaccines against vesicular stomatitis

 #94
20080107687
2008-05-08

FELINE VACCINES AGAINST AVIAN INFLUENZA

 #95
20080107681
2008-05-08

Feline vaccines against avian influenza

 #96
20080075736
2008-03-27

Materials and methods for respiratory disease control in canines

 #97
20080044377
2008-02-21

Poxvirus Vector Encoding Retrovirus (Eg Hiv) And Cytokine

 #98
20070280960
2007-12-06

Recombinant vaccine against bluetongue virus

 #99
20070196346
2007-08-23

Poxvirus Vector Encoding Prostate Specific Antigens For Treatment Of Prostate Cancer

 #100
20070110718
2007-05-17

System for treating and preventing breast cancer

 #101
20070048860
2007-03-01

Carcinoembryonic antigen (CEA) peptides

 #102
20070048821
2007-03-01

Canine influenza vaccines

 #103
20070031455
2007-02-08

Nipah virus vaccines

 #104
20060240042
2006-10-26

Methods of potentiating HIV-1-specific CD8+ immune responses involving the concomitant administration of DNA and ALVAC expression vectors

 #105
20060240039
2006-10-26

Vaccines

 #106
20060216312
2006-09-28

Mutants of replication competent vaccinia virus

 #107
20060210537
2006-09-21

Theileria parva DNA vaccines

 #108
20060160101
2006-07-20

Inactivated FCV vaccines

 #109
20060159706
2006-07-20

Insertion sites in fowlpox vectors

 #110
20060094006
2006-05-04

Immunotherapy regimens in hiv-infected patients

 #111
20060073594
2006-04-06

Chimeric vectors

 #112
20060034867
2006-02-16

Needle-free administration of FeLV vaccines

 #113
20060029617
2006-02-09

Porcine circovirus and Helicobacter combination vaccines and methods of use

 #114
20050287672
2005-12-29

Avipox recombinants expressing foot and mouth disease virus genes

 #115
20050287174
2005-12-29

Immunizing against HIV infection

 #116
20050287162
2005-12-29

Recombinant fowlpox virus

 #117
20050255127
2005-11-17

Recombinant vaccine against West Nile Virus

 #118
20050208022
2005-09-22

Method for augmenting vision in persons suffering from photoreceptor cell degeneration

 #119
20050208020
2005-09-22

Enhancement of vaccine-induced immune responses and protection by heterologous boosting with alphavirus replicon vaccines

 #120
20050124070
2005-06-09

VAC-BAC shuttle vector system

 #121
20050106123
2005-05-19

Method of inducing an enhanced immune response against hiv

 #122
20050058653
2005-03-17

Prevention of myocarditis, abortion and intrauterine infection associated with porcine circovirus-2

 #123
20050053620
2005-03-10

Recombinant vaccinia virus vaccine

 #124
20050025747
2005-02-03

Vaccine

 #125
20050019752
2005-01-27

Novel chimeric rev, tat, and nef antigens

 #126
16855115
2023-02-28

Apoptotic upregulation by myxoma virus expressing walleye dermal sarcoma virus orfC